Moderate-certainty evidence finds that large reductions in COVID-19 deaths are possible using ivermectin. Using ivermectin early in the clinical course may reduce numbers progressing to severe disease.
One of the few papers giving clear support to ivermectin as a prophylactic drug against covid19.
Has been partially refuted by politifact, and accused 1st author Andrew Bryant of hiding conflict-of-interest.